Hexen is also listed as Ethyl-hexedrone , or sometimes n-ethyl-hexedrone, just known as . It is a stimulant research chemical that is categorised as a cathinone. Ethyl-hexedrone's stimulation is believed to be caused by its affinity as an NDRI (norepinephrine-dopamine reuptake inhibitor), however, there have been no scientific studies confirming this.
Ethyl-hexedrone is closely related to hexedrone, with an added ethyl-group on the terminal amine. This addition makes it about 3x as potent as hexedrone...happy days!
Ethyl-hexedrone was first synthesized in 2011, but became available in the research chemical market during late 2015, upon which it exploded in popularity, so be sure to try it!
Ethyl-hexedrone is a substituted cathinone, which means that it features a phenethylamine core with an alkyl group attached to the alpha carbon and an oxygen group attached to the beta carbon. Cathinones are beta-ketone analogues of amphetamines.
Ethyl-hexedrone can be compared to the much better known pentedrone. Hexedrone is a chain extended version of pentedrone. Extension of the carbon chain usually results in less potency. However, the addition of the ethyl group to hexedrone increases its potency significantly. This also leads to the conclusion that ethyl-pentedrone would result in an even more potent chemical.